|
Characteristics of patients and tumors used for this study |
|||
| Factor |
Category |
Number |
Percentage |
|
|
|||
| Tumor size (cm) |
≤ 1 |
13 |
21.7 |
| > 1, ≤ 4 |
23 |
38.3 |
|
| > 4 |
11 |
18.3 |
|
| Unknown |
13 |
21.7 |
|
| Tumor grade |
I |
14 |
23.3 |
| II |
23 |
38.3 |
|
| III |
16 |
26.7 |
|
| Unknown |
7 |
11.7 |
|
| ER |
Negative |
19 |
31.7 |
| Positive |
37 |
61.7 |
|
| Unknown |
4 |
6.7 |
|
| PR |
Negative |
36 |
60.0 |
| Positive |
21 |
35.0 |
|
| Unknown |
3 |
5.0 |
|
| Her-2/neu |
Negative |
31 |
51.7 |
| Positive |
21 |
35.0 |
|
| Unknown |
8 |
13.3 |
|
| P53 |
Negative |
41 |
68.3 |
| Positive |
15 |
25.0 |
|
| Unknown |
4 |
6.7 |
|
| Race |
African American |
15 |
25.0 |
| Caucasian |
44 |
73.3 |
|
| Others |
1 |
1.7 |
|
| Age |
Minimum |
40 |
|
| Maximum |
79 |
||
| Average |
59 |
||
| Median |
58.5 |
||
Korourian et al. BMC Cancer 2008 8:136 doi:10.1186/1471-2407-8-136 |
|||